References
- Sotherland G A, Glass J, Gabriel R. Increased incidence of malignancy in chronic renal failure. Nephron 1977; 18: 182
- Miyakawa M, Sugimoto K, Yasui, et al. A chemotherapy regimen including CDDP for patients with gastric cancer during hemodialysis. Kidney Hemodialysis 1987; 23: 179, (in Japanese)
- Suwata J, Hiraga S, Hida M, et al. Study on changes in plasma platinum concentration after administration of CDDP to maintenance hemodialysis patients. Jap J Cancer Chemother 1988; 15: 243, (in Japanese)
- Kurokawa J, Tobita M, Hiraga S, et al. Study on change of plasma platinum concentration after blood purification methods in dialysis patients with CDDP therapy. Jpn J Artif Organs 1987; 16: 774
- Pera M F, Harder H C. Analysis for platinum in biological material by nameless atomic absorption spectrometry. Clin Chem 1977; 23: 1245
- Gibali M, Perrier D. One compartment models and multicompartment models. Pharmacokinetics. Marcel Dekker, New York 1975; 1–4; 45–96
- Yamaoka K, Tanigawara Y, Nakagawa T, Uno T. A pharmacokinetic program(MULTT) for microcomputer. J Pharmacobio Dyn 1981; 4: 879
- Reidenberg M M. The binding of drugs to plasma protein and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. Am J Med 1977; 62: 466
- Belt R J, Himmelstein K J, Patton T F, et al. Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlordiammineplatinum(II). Cancer Treat Rep 1979; 63: 1515
- Forastiere A A, Belliveau J F, Goren M P, et al. Pharmacokinetics and toxicity evaluation of five day continuous infusion versus intermittent bolus cis-diamminedichlorplatinum(II) in head and neck cancer patients. Cancer Res 1988; 48: 3869
- Keller F, Wilms H, Shultze G, et al. Effect of plasma protein binding, volume of distribution and molecular weight on the fraction of drugs eliminated by hemodyalisis. Clin Nephrol 1983; 19: 201
- Bennet W M, Singer I, Golper, et al. Guidelines for drug therapy in renal failure. Ann Intern Med 1977; 86: 754
- Holthuis J JM, Van de Vyer F L, Van Oort, et al. Pharmacokinetic evaluation of increasing dosage of etoposide in a chronic hemodialysis patient. Cancer Treat Rep 1983; 69: 1279
- Tamura J, Kamato T, Azuma N, et al. Absorption of 5-FU orally administered to a patient with postoperative gastric cancer under artificial dialysis. Jpn J Cancer Chemother 1987; 14: 2271
- Einhorn L H. Testicular cancer as a model for a curable neoplasm; The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1981; 41: 3275
- Hogan W N. Gynecologic malignancies. Cancer Chemotherapy. Excerpta Medica, Amsterdam 1982; 3098
- Gralla R J, Casper E S, Kelsen D P. Cisplatin and vindesin combination chemotherapy for advanced carcinoma of the lung; A randomized trial investigating two dosage schedules. Ann Intern Med 1981; 95: 414
- Lacave A J, Pedera M V, Izarzugaza I, et al. Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer. Am J Clin Oncol 1983; 6: 35
- Blumenreich M S, Woodcock T M, Tones, et al. High-dose cisplatin in patients with advanced malignancies. Cancer 1985; 55: 1118
- Williams S D, Donohue J P, Einhorn L H. Advanced bladder cancer: Therapy with cis-dichlorplatinum(II) adriamycin and 5-fluouracil. Cancer Treat Rep 1980; 64: 1573
- Lockich J J. Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusion. Cancer Treat Rep 1979; 63: 1573
- Gullo J J, Litterst C L, Maguire, et al. Pharmacokinetics and protein binding of cis-dichlorodiamineplatinum (II) administered as a one hour or as twenty hour infusion. Cancer Chemother Pharmacol 1980; 5: 21
- Vermorken J B, Van der Vijgh W JF, Klein I, et al. Pharmacokinetics of free and total platinum species after rapid and prolonged infusion of cis-platin. Clin Pharmacol Ther 1986; 39: 136
- Rapta A J, Long D F. Reaction of cis-platin with human plasma and plasma fraction. Cisplatin: Current Status and New Development. Academic Press, New York 1980; 285–304
- Blackey J D, Hill J B. Renal and electrolytes disturbance associated with cisplatin. Ann Int Med 1981; 95: 628
- Gormeley P E, Bull J M, LeRoy A F. Kinetics of cis-dichlorodiammineplatinum. Clin Pharmacol Ther 1979; 25: 351
- Himmelstein K J, Patton T F, Belt R J, et al. Clinical kinetics of intact cisplatin and some related species. Gin Pharmacol Ther 1981; 29: 658
- Manaka R C, Wolf W. Distribution of cis-platin in blood. Chem Biol Interact 1978; 22: 353